_id
6918435d3c536f8df2317702
Ticker
XAGE
Name
Longevity Health Holdings, Inc.
Exchange
NASDAQ
Address
2403 Sidney Street, Pittsburgh, PA, United States, 15203
Country
USA
Sector
Consumer Defensive
Industry
Household & Personal Products
Currency
USD
Website
https://www.carmellcosmetics.com
Description
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Last Close
0.329
Volume
-
Current Price
0.329
Change
-20.45454545454546
Last Updated
2026-01-08T13:02:26.475Z
Image
https://logo.clearbit.com/www.carmellcosmetics.com
Ipo Date
2021-09-23T00:00:00.000Z
Market Cap
536125
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.99
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
425864
Cost Of Revenue
218483
Gross Profit
207381
Operating Expenses
1678398
Operating Income
-1471017
Interest Expense
5059
Pretax Income
-1429755
Net Income
-1429755
Eps
-0.8295966077029929
Dividends Per Share
-
Shares Outstanding
1781738
Income Tax Expense
-
EBITDA
-1501831
Operating Margin
-345.41942967708
Total Other Income Expense Net
41262
Cash
1109228
Short Term Investments
-
Receivables
46522
Inventories
1013368
Total Current Assets
2843947
Property Plant Equipment
438801
Total Assets
3298979
Payables
4171099
Short Term Debt
379373
Long Term Debt
-
Total Liabilities
7276342
Equity
-3977363
Bs_currency_symbol
USD
Depreciation
37647
Change In Working Capital
263205
Cash From Operations
-1433756
Capital Expenditures
14224
Cash From Investing
776
Cash From Financing
991009
Net Change In Cash
-441971
Cf_currency_symbol
USD
PE
-
PB
-0.14255922479290928
ROE
35.94730981305956
ROA
-43.339318013239854
FCF
-1447980
Fcf Percent
-3.40009956230158
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
425864
Quarters > 0 > income Statement > cost Of Revenue
218483
Quarters > 0 > income Statement > gross Profit
207381
Quarters > 0 > income Statement > operating Expenses
1678398
Quarters > 0 > income Statement > operating Income
-1471017
Quarters > 0 > income Statement > interest Expense
5059
Quarters > 0 > income Statement > pretax Income
-1429755
Quarters > 0 > income Statement > net Income
-1429755
Quarters > 0 > income Statement > eps
-0.8295966077029929
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1723434
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1501831
Quarters > 0 > income Statement > operating Margin
-345.41942967708
Quarters > 0 > income Statement > total Other Income Expense Net
41262
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1109228
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
46522
Quarters > 0 > balance Sheet > inventories
1013368
Quarters > 0 > balance Sheet > total Current Assets
2843947
Quarters > 0 > balance Sheet > property Plant Equipment
438801
Quarters > 0 > balance Sheet > total Assets
3298979
Quarters > 0 > balance Sheet > payables
4171099
Quarters > 0 > balance Sheet > short Term Debt
379373
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7276342
Quarters > 0 > balance Sheet > equity
-3977363
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1429755
Quarters > 0 > cash Flow > depreciation
37647
Quarters > 0 > cash Flow > change In Working Capital
263205
Quarters > 0 > cash Flow > cash From Operations
-1433756
Quarters > 0 > cash Flow > capital Expenditures
14224
Quarters > 0 > cash Flow > cash From Investing
776
Quarters > 0 > cash Flow > cash From Financing
991009
Quarters > 0 > cash Flow > net Change In Cash
-441971
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.8295966077029929
Quarters > 0 > ratios > PB
-0.14255922479290928
Quarters > 0 > ratios > ROE
35.94730981305956
Quarters > 0 > ratios > ROA
-43.339318013239854
Quarters > 0 > ratios > FCF
-1447980
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-3.40009956230158
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
503612
Quarters > 1 > income Statement > cost Of Revenue
200954
Quarters > 1 > income Statement > gross Profit
302658
Quarters > 1 > income Statement > operating Expenses
2161262
Quarters > 1 > income Statement > operating Income
-1858604
Quarters > 1 > income Statement > interest Expense
2561
Quarters > 1 > income Statement > pretax Income
-1886438
Quarters > 1 > income Statement > net Income
-1886438
Quarters > 1 > income Statement > eps
-0.09023684638141702
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
20905407
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1818275
Quarters > 1 > income Statement > operating Margin
-369.05474849685874
Quarters > 1 > income Statement > total Other Income Expense Net
-27834
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1551199
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
356334
Quarters > 1 > balance Sheet > inventories
1172634
Quarters > 1 > balance Sheet > total Current Assets
3240887
Quarters > 1 > balance Sheet > property Plant Equipment
461088
Quarters > 1 > balance Sheet > total Assets
3719342
Quarters > 1 > balance Sheet > payables
4590542
Quarters > 1 > balance Sheet > short Term Debt
108145
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7456876
Quarters > 1 > balance Sheet > equity
-3737534
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1886438
Quarters > 1 > cash Flow > depreciation
65602
Quarters > 1 > cash Flow > change In Working Capital
760693
Quarters > 1 > cash Flow > cash From Operations
-836190
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-15000
Quarters > 1 > cash Flow > cash From Financing
1632342
Quarters > 1 > cash Flow > net Change In Cash
781152
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.09023684638141702
Quarters > 1 > ratios > PB
-1.8402184175448304
Quarters > 1 > ratios > ROE
50.47279837454322
Quarters > 1 > ratios > ROA
-50.719670307274775
Quarters > 1 > ratios > FCF
-836190
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.660385376043462
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
510353
Quarters > 2 > income Statement > cost Of Revenue
240530
Quarters > 2 > income Statement > gross Profit
269823
Quarters > 2 > income Statement > operating Expenses
1776574
Quarters > 2 > income Statement > operating Income
-1506751
Quarters > 2 > income Statement > interest Expense
4993
Quarters > 2 > income Statement > pretax Income
-1505867
Quarters > 2 > income Statement > net Income
-1505867
Quarters > 2 > income Statement > eps
-0.07203241725932434
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
20905407
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1427166
Quarters > 2 > income Statement > operating Margin
-295.23702221795503
Quarters > 2 > income Statement > total Other Income Expense Net
884
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
770047
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
396591
Quarters > 2 > balance Sheet > inventories
1379640
Quarters > 2 > balance Sheet > total Current Assets
2793177
Quarters > 2 > balance Sheet > property Plant Equipment
525553
Quarters > 2 > balance Sheet > total Assets
3337234
Quarters > 2 > balance Sheet > payables
4598791
Quarters > 2 > balance Sheet > short Term Debt
232982
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7142519
Quarters > 2 > balance Sheet > equity
-3805285
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1505867
Quarters > 2 > cash Flow > depreciation
73708
Quarters > 2 > cash Flow > change In Working Capital
564377
Quarters > 2 > cash Flow > cash From Operations
-752953
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-150000
Quarters > 2 > cash Flow > cash From Financing
1515861
Quarters > 2 > cash Flow > net Change In Cash
612908
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.07203241725932434
Quarters > 2 > ratios > PB
-1.8074543438927704
Quarters > 2 > ratios > ROE
39.57304117825603
Quarters > 2 > ratios > ROA
-45.123206823375284
Quarters > 2 > ratios > FCF
-752953
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.4753572527250747
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
17479
Quarters > 3 > income Statement > cost Of Revenue
1225
Quarters > 3 > income Statement > gross Profit
16254
Quarters > 3 > income Statement > operating Expenses
1023131
Quarters > 3 > income Statement > operating Income
-1006877
Quarters > 3 > income Statement > interest Expense
7513
Quarters > 3 > income Statement > pretax Income
-1011562
Quarters > 3 > income Statement > net Income
-914283
Quarters > 3 > income Statement > eps
-0.04373428367120525
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
20905407
Quarters > 3 > income Statement > income Tax Expense
-97279
Quarters > 3 > income Statement > EBITDA
-965510
Quarters > 3 > income Statement > operating Margin
-5760.495451684879
Quarters > 3 > income Statement > total Other Income Expense Net
-4685
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
157139
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
305934
Quarters > 3 > balance Sheet > inventories
108705
Quarters > 3 > balance Sheet > total Current Assets
955554
Quarters > 3 > balance Sheet > property Plant Equipment
498785
Quarters > 3 > balance Sheet > total Assets
1473980
Quarters > 3 > balance Sheet > payables
4058091
Quarters > 3 > balance Sheet > short Term Debt
329056
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6186642
Quarters > 3 > balance Sheet > equity
-4712662
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-814283
Quarters > 3 > cash Flow > depreciation
38539
Quarters > 3 > cash Flow > change In Working Capital
-262497
Quarters > 3 > cash Flow > cash From Operations
-772063
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-208123
Quarters > 3 > cash Flow > net Change In Cash
-980186
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.04373428367120525
Quarters > 3 > ratios > PB
-1.4594466785438889
Quarters > 3 > ratios > ROE
19.40056384268594
Quarters > 3 > ratios > ROA
-62.0281822005726
Quarters > 3 > ratios > FCF
-772063
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-44.17089078322559
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
50318
Annuals > 0 > income Statement > cost Of Revenue
6357
Annuals > 0 > income Statement > gross Profit
43961
Annuals > 0 > income Statement > operating Expenses
5042459
Annuals > 0 > income Statement > operating Income
-4998498
Annuals > 0 > income Statement > interest Expense
49015
Annuals > 0 > income Statement > pretax Income
-10747743
Annuals > 0 > income Statement > net Income
-10368261
Annuals > 0 > income Statement > eps
-0.49596073398618834
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
20905407
Annuals > 0 > income Statement > income Tax Expense
-97279
Annuals > 0 > income Statement > EBITDA
-10501468
Annuals > 0 > income Statement > operating Margin
-9933.816924361063
Annuals > 0 > income Statement > total Other Income Expense Net
-5749245
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
157139
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
305934
Annuals > 0 > balance Sheet > inventories
108705
Annuals > 0 > balance Sheet > total Current Assets
955554
Annuals > 0 > balance Sheet > property Plant Equipment
498785
Annuals > 0 > balance Sheet > total Assets
1473980
Annuals > 0 > balance Sheet > payables
4058091
Annuals > 0 > balance Sheet > short Term Debt
329056
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6186642
Annuals > 0 > balance Sheet > equity
-4712662
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11802740
Annuals > 0 > cash Flow > depreciation
197260
Annuals > 0 > cash Flow > change In Working Capital
669489
Annuals > 0 > cash Flow > cash From Operations
-4388948
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-748796
Annuals > 0 > cash Flow > cash From Financing
2382422
Annuals > 0 > cash Flow > net Change In Cash
-2755322
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.49596073398618834
Annuals > 0 > ratios > PB
-1.4594466785438889
Annuals > 0 > ratios > ROE
220.00858538125584
Annuals > 0 > ratios > ROA
-703.4193815384198
Annuals > 0 > ratios > FCF
-4388948
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-87.22421399896658
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
124788
Annuals > 1 > income Statement > gross Profit
-124788
Annuals > 1 > income Statement > operating Expenses
5092488
Annuals > 1 > income Statement > operating Income
-5217280
Annuals > 1 > income Statement > interest Expense
889318
Annuals > 1 > income Statement > pretax Income
-16205252
Annuals > 1 > income Statement > net Income
-15445087
Annuals > 1 > income Statement > eps
-0.7435372677602468
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
20772445
Annuals > 1 > income Statement > income Tax Expense
-760163
Annuals > 1 > income Statement > EBITDA
-15191148
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-10987976
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2912461
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
204559
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
62900114
Annuals > 1 > balance Sheet > property Plant Equipment
1024502
Annuals > 1 > balance Sheet > total Assets
63948803
Annuals > 1 > balance Sheet > payables
4417234
Annuals > 1 > balance Sheet > short Term Debt
1438734
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
39199793
Annuals > 1 > balance Sheet > equity
24749010
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-15445087
Annuals > 1 > cash Flow > depreciation
124788
Annuals > 1 > cash Flow > change In Working Capital
-3422254
Annuals > 1 > cash Flow > cash From Operations
-8348208
Annuals > 1 > cash Flow > capital Expenditures
30470
Annuals > 1 > cash Flow > cash From Investing
-30470
Annuals > 1 > cash Flow > cash From Financing
11162990
Annuals > 1 > cash Flow > net Change In Cash
2784312
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.7435372677602468
Annuals > 1 > ratios > PB
0.276137688133788
Annuals > 1 > ratios > ROE
-62.40688819471971
Annuals > 1 > ratios > ROA
-24.15226912065891
Annuals > 1 > ratios > FCF
-8378678
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
242556
Annuals > 2 > income Statement > gross Profit
-242556
Annuals > 2 > income Statement > operating Expenses
5265085
Annuals > 2 > income Statement > operating Income
-5507641
Annuals > 2 > income Statement > interest Expense
3749210
Annuals > 2 > income Statement > pretax Income
-9051334
Annuals > 2 > income Statement > net Income
-9051334
Annuals > 2 > income Statement > eps
-0.4578546696139731
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19769011
Annuals > 2 > income Statement > income Tax Expense
391198
Annuals > 2 > income Statement > EBITDA
-5059570
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-3543693
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
128149
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
605540
Annuals > 2 > balance Sheet > property Plant Equipment
1114305
Annuals > 2 > balance Sheet > total Assets
1748547
Annuals > 2 > balance Sheet > payables
2138732
Annuals > 2 > balance Sheet > short Term Debt
2907280
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
39539086
Annuals > 2 > balance Sheet > equity
-37790539
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-9051334
Annuals > 2 > cash Flow > depreciation
242556
Annuals > 2 > cash Flow > change In Working Capital
2338501
Annuals > 2 > cash Flow > cash From Operations
-3810929
Annuals > 2 > cash Flow > capital Expenditures
7164
Annuals > 2 > cash Flow > cash From Investing
-7164
Annuals > 2 > cash Flow > cash From Financing
3933880
Annuals > 2 > cash Flow > net Change In Cash
115787
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.4578546696139731
Annuals > 2 > ratios > PB
-0.17210669101597095
Annuals > 2 > ratios > ROE
23.951322843000465
Annuals > 2 > ratios > ROA
-517.6488821861809
Annuals > 2 > ratios > FCF
-3818093
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1940332
Annuals > 3 > income Statement > operating Income
-467431
Annuals > 3 > income Statement > interest Expense
2499084
Annuals > 3 > income Statement > pretax Income
-329382
Annuals > 3 > income Statement > net Income
-6478923
Annuals > 3 > income Statement > eps
-0.3277312658685859
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19769011
Annuals > 3 > income Statement > income Tax Expense
2536462
Annuals > 3 > income Statement > EBITDA
-87253
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
138049
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
774192
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
178704
Annuals > 3 > balance Sheet > property Plant Equipment
1345181
Annuals > 3 > balance Sheet > total Assets
1557103
Annuals > 3 > balance Sheet > payables
871313
Annuals > 3 > balance Sheet > short Term Debt
8723594
Annuals > 3 > balance Sheet > long Term Debt
922
Annuals > 3 > balance Sheet > total Liabilities
31134149
Annuals > 3 > balance Sheet > equity
-29577046
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6478923
Annuals > 3 > cash Flow > depreciation
242124
Annuals > 3 > cash Flow > change In Working Capital
952689
Annuals > 3 > cash Flow > cash From Operations
-1176829
Annuals > 3 > cash Flow > capital Expenditures
7273
Annuals > 3 > cash Flow > cash From Investing
-7273
Annuals > 3 > cash Flow > cash From Financing
1195314
Annuals > 3 > cash Flow > net Change In Cash
11212
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.3277312658685859
Annuals > 3 > ratios > PB
-0.21990041260374685
Annuals > 3 > ratios > ROE
21.905240300197658
Annuals > 3 > ratios > ROA
-416.0882741861007
Annuals > 3 > ratios > FCF
-1184102
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.8295966077029929
Valuation > metrics > PB
-0.14255922479290928
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
35.94730981305956
Profitability > metrics > ROA
-50.273616210147374
Profitability > metrics > Net Margin
-3.3573042097946764
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-290.7722870132437
Risk > final Score
-1133
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.6249784637725493
Liquidity > metrics > Quick Ratio
0.40228332357610375
Liquidity > final Score
30
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
39
Prev Risks > 0
-2873
Prev Risks > 1
-1177
Prev Risks > 2
-506
Prev Liquidities > 0
32
Prev Liquidities > 1
25
Prev Liquidities > 2
20
Updated At
2026-01-20T22:50:30.633Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.83
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.83
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.56
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.52
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.04
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-4.1307
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-4.7811
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-4.2823
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-09-30
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-18.5416
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-06-30
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.4818
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-03-31
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.8742
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2023-03-17
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0.01
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-10
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0.04
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-08-10
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.02
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-04-15
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-12-31
Earnings History > 14 > report Date
2021-12-31
Earnings History > 14 > date
2021-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.3559
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-11-22
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-07-27
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAnalyst Downgrade: Is XAGE likely to announce a buyback - 2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans baoquankhu1.vn
Read more →Will INBS stock deliver strong dividend growth - Earnings Miss & Consistent Income Trade Ideas bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Longevity Health Holdings, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.83
EPS Estimate
0
EPS Difference
-0.83
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.